Product information and disease descriptionPlace of product in therapyApproaches to treatment
Expected outcomes of therapy
5 evidence topics · 4 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionPlace of product in therapyApproaches to treatment
5 evidence topics · 4 sources